


0

Canrib 150mg Tablet is currently sold out
Same composition alternative:
Obparp 150 Tablet
₹1745₹2208.93
Available alternative from Cipla
Sold out

Canrib 150mg Tablet
strip of 60 tablets
₹11009

Same composition
Obparp 150 Tablet
strip of 8 tablets
by Cipla Ltd
Get by Mon, 12 Oct
₹1745
₹218.12 per tablet
Save more with additional offers

Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).

Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.

Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.

Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI (@ikwik).

Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.

Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.

Assured cashback up to ₹300*. T&C Apply*
Assured cashback up to ₹300*. T&C Apply*
General Information
The content is shown in English



Uses of Canrib Tablet
Benefits of Canrib Tablet
Treatment of Breast cancer
Canrib 150mg Tablet provides a targeted treatment option that specifically attacks cancer cells while sparing most healthy cells. Clinical studies have shown that Canrib 150mg Tablet can significantly reduce the risk of cancer progression or recurrence and improve survival rates. By specifically inhibiting the PARP enzyme in cancer cells, Canrib 150mg Tablet helps to slow the spread of the disease, providing patients with a more effective and less toxic treatment option.
Canrib 150mg Tablet provides a targeted treatment option that specifically attacks cancer cells while sparing most healthy cells. Clinical studies have shown that Canrib 150mg Tablet can significantly reduce the risk of cancer progression or recurrence and improve survival rates. By specifically inhibiting the PARP enzyme in cancer cells, Canrib 150mg Tablet helps to slow the spread of the disease, providing patients with a more effective and less toxic treatment option.
Treatment of Ovarian cancer
Canrib 150mg Tablet helps prevent the cancer from worsening for a longer period. The medicine is effective in both newly diagnosed cases and in recurrent ovarian cancer, offering a maintenance therapy option that can delay the need for further chemotherapy. This targeted therapy can lead to better management of the disease with a more personalized approach, improving overall outcomes and quality of life for patients.
Canrib 150mg Tablet helps prevent the cancer from worsening for a longer period. The medicine is effective in both newly diagnosed cases and in recurrent ovarian cancer, offering a maintenance therapy option that can delay the need for further chemotherapy. This targeted therapy can lead to better management of the disease with a more personalized approach, improving overall outcomes and quality of life for patients.
Side effects of Canrib Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Canrib
- Nausea
- Vomiting
- Fatigue
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased blood cells (red cells, white cells, and platelets)
- Taste change
- Cough
- Breathlessness
- Indigestion
- Abdominal pain
- Loss of appetite
- Headache
- Decreased white blood cell count (neutrophils)
How to use Canrib Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Canrib 150mg Tablet may be taken with or without food.
How Canrib Tablet works
Canrib 150mg Tablet is an anticancer medication. It works by inhibiting the growth of select tumor cell lines in vitro and decrease tumor growth in both as monotherapy or following chemotherapy.
All substitutes for Canrib 150mg Tablet
For information purposes only. Consult a doctor before taking any medicine.
Ribaxapi 150 mg Tablet
by Dr. Reddy's Laboratories Ltd.
₹199.1/tablet
9% costlier
Olparib 150mg Tablet
by Glenmark Pharmaceuticals Ltd
₹200.68/tablet
9% costlier
Lynparza 150mg Tablet
by AstraZeneca
₹4614.75/tablet
2415% costlier
Obrenza 150 Tablet
by Sun Pharmaceutical Industries Ltd
₹323.13/tablet
76% costlier
Obparp 150 Tablet
by Cipla Ltd
₹218.13/tablet
19% costlier
Quick tips
- Take Canrib 150mg Tablet exactly as prescribed by your doctor. Do not alter your dose without consulting your doctor.
- Drinking plenty of fluids can help reduce some side effects, such as nausea and vomiting. Try to drink at least 8-10 glasses of water each day.
- Canrib 150mg Tablet can affect your blood cell counts. Ensure you have regular blood tests as recommended by your doctor to monitor for potential issues like anemia or low white blood cell counts.
- Canrib 150mg Tablet can harm an unborn baby. Women should use effective contraception during treatment and for a period after the last dose. Men with female partners of reproductive potential should also use effective contraception during treatment and for a specified time afterward.
- Maintain a healthy lifestyle by eating a balanced diet, getting regular exercise, and managing stress. This can help improve your overall well-being during treatment.
Safety advice

Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Canrib 150mg Tablet. Please consult your doctor.

Pregnancy
UNSAFE
Canrib 150mg Tablet is highly unsafe during pregnancy. It can cause serious harm to the unborn baby, including birth defects and pregnancy loss. Do not use this medicine if you are pregnant or planning to become pregnant.

Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Canrib 150mg Tablet during breastfeeding is not available. Please consult your doctor.

Driving
UNSAFE
Canrib 150mg Tablet may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney
CAUTION
Canrib 150mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment may be needed.

Liver
CAUTION
Canrib 150mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment may be needed.
Interaction with drugs
Taking Canrib with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Severe
Phenobarbitone (Injection Route)
Do not consume Olaparib with Phenobarbitone. Phenobarbitone may reduce blood levels of Olaparib.
Severe
Phenytoin (Oral Route)
Do not consume Olaparib with Phenytoin. Phenytoin may reduce blood levels of Olaparib.
Severe
Phenytoin (Injection Route)
Do not consume Olaparib with Phenytoin. Phenytoin may reduce blood levels of Olaparib.
Severe
Apalutamide (Oral Route)
Do not consume Olaparib with Apalutamide. Apalutamide may reduce blood levels of Olaparib.
Severe
Carbamazepine (Oral Route)
Do not consume Olaparib with Carbamazepine. Carbamazepine may reduce blood levels of Olaparib.
Frequently asked questions
Canrib 150mg Tablet is a prescription medication used to treat ovarian and breast cancer. It works by blocking an enzyme involved in repairing damaged DNA, thereby helping to kill cancer cells.
Before starting Canrib 150mg Tablet, inform your doctor about any other medications you are taking, any allergies, and your medical history, especially if you have kidney or liver problems, lung issues, or are planning to become pregnant or are breastfeeding.
Some medications may interact with Canrib 150mg Tablet, affecting how it works or increasing the risk of side effects. Always inform your doctor about all the medications and supplements you are taking to ensure there are no harmful interactions.
Canrib 150mg Tablet can harm an unborn baby. It is important to avoid pregnancy while taking Canrib 150mg Tablet and for a period after the last dose. Women should use effective contraception during treatment and for a specified time after the last dose. Breastfeeding is not recommended during treatment with Canrib 150mg Tablet and for a period after the last dose.
The duration of treatment varies depending on the type of cancer being treated, the patient’s response to the medication, and the presence of any side effects. Your doctor will determine the appropriate length of treatment.
Canrib 150mg Tablet is a prescription medication used to treat ovarian and breast cancer. It works by blocking an enzyme involved in repairing damaged DNA, thereby helping to kill cancer cells.
Before starting Canrib 150mg Tablet, inform your doctor about any other medications you are taking, any allergies, and your medical history, especially if you have kidney or liver problems, lung issues, or are planning to become pregnant or are breastfeeding.
Some medications may interact with Canrib 150mg Tablet, affecting how it works or increasing the risk of side effects. Always inform your doctor about all the medications and supplements you are taking to ensure there are no harmful interactions.
Canrib 150mg Tablet can harm an unborn baby. It is important to avoid pregnancy while taking Canrib 150mg Tablet and for a period after the last dose. Women should use effective contraception during treatment and for a specified time after the last dose. Breastfeeding is not recommended during treatment with Canrib 150mg Tablet and for a period after the last dose.
The duration of treatment varies depending on the type of cancer being treated, the patient’s response to the medication, and the presence of any side effects. Your doctor will determine the appropriate length of treatment.
Fact Box
Chemical Class
Phthalazinones
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
PARP Inhibitor
Related lab tests
References
- Olaparib [Prescribing Information]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2020. [Accessed 17 Jul. 2024] (online) Available from:
- Lynparza (Olaparib) [Product Information]. [Accessed 17 Jul. 2024] (online) Available from:
- Lynparza (Olaparib) [Product Information]. [Accessed 17 Jul. 2024] (online) Available from:
- Olaparib [Prescribing Information]. London, UK: AstraZeneca UK Limited; 2023. [Accessed 17 Jul. 2024] (online) Available from:
- Olaparib [Summary of Product Characteristics]. Södertälje, Sweden: AstraZeneca AB; 2022. [Accessed 17 Jul. 2024] (online) Available from:
- Olaparib [Prescribing Information]. Mississauga, Ontario: AstraZeneca Canada Inc. 2024. [Accessed 17 Jul. 2024] (online) Available from:
Related products
Products related to Canrib 150mg Tablet

100% genuine products

Safe & secure payments

No contact delivery

Fully sanitized facilities
Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
Marketer details
Name: Adley Formulations
Address: Adley Formulation, SCO- 42, Sector 12, Panchkula-134112, Haryana, India
Address: Adley Formulation, SCO- 42, Sector 12, Panchkula-134112, Haryana, India
Vendor Details
Country of origin: India
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)
Why we need a prescription?
















